Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov 1;25(21):4941-4944.
doi: 10.1016/j.bmcl.2015.04.074. Epub 2015 May 1.

Discovery of a novel Kv7 channel opener as a treatment for epilepsy

Jennifer E Davoren  1 , Michelle M Claffey  2 , Sheri L Snow  2 , Matthew R Reese  2 , Gaurav Arora  2 , Christopher R Butler  1 , Brian P Boscoe  2 , Lois Chenard  2 , Shari L DeNinno  2 , Susan E Drozda  2 , Allen J Duplantier  2 , Ludivine Moine  2 , Bruce N Rogers  2 , SuoBao Rong  2 , Katherine Schuyten  2 , Ann S Wright  2 , Lei Zhang  1 , Kevin A Serpa  2 , Mark L Weber  2 , Polina Stolyar  1 , Tammy L Whisman  2 , Karen Baker  2 , Karen Tse  3 , Alan J Clark  2 , Haojing Rong  2 , Robert J Mather  4 , John A Lowe 3rd  5
Affiliations

Discovery of a novel Kv7 channel opener as a treatment for epilepsy

Jennifer E Davoren et al. Bioorg Med Chem Lett. .

Abstract

Facilitating activation, or delaying inactivation, of the native Kv7 channel reduces neuronal excitability, which may be beneficial in controlling spontaneous electrical activity during epileptic seizures. In an effort to identify a compound with such properties, the structure-activity relationship (SAR) and in vitro ADME for a series of heterocyclic Kv7.2-7.5 channel openers was explored. PF-05020182 (2) demonstrated suitable properties for further testing in vivo where it dose-dependently decreased the number of animals exhibiting full tonic extension convulsions in response to corneal stimulation in the maximal electroshock (MES) assay. In addition, PF-05020182 (2) significantly inhibited convulsions in the MES assay at doses tested, consistent with in vitro activity measure. The physiochemical properties, in vitro and in vivo activities of PF-05020182 (2) support further development as an adjunctive treatment of refractory epilepsy.

Keywords: Amygdala-kindled seizure; Dimethoxypyrimidine; KCNQ; Kv7 channel opener; Maximal electroshock; PF-05020182; Pentylenetetrazole-induced seizure.

PubMed Disclaimer

MeSH terms